Advisor Shares Investments LLC Neurocrine Biosciences Inc Transaction History
Advisor Shares Investments LLC
- $489 Million
- Q1 2025
A detailed history of Advisor Shares Investments LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Advisor Shares Investments LLC holds 3,566 shares of NBIX stock, worth $431,557. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,566
Previous 2,030
75.67%
Holding current value
$431,557
Previous $277,000
42.24%
% of portfolio
0.08%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
652Shares Held
97.2MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.72 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.2 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$670 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$588 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$323 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...